RET fusion-positive thyroid cancer

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:cancer
gptkbp:FDAApproved	gptkb:pralsetinib gptkb:selpercatinib
gptkbp:hasBiomarker	gptkb:RET_fusion
gptkbp:hasCommonFusionPartner	gptkb:CCDC6 gptkb:KIF5B gptkb:NCOA4
gptkbp:hasDiagnosticMethod	gptkb:FISH gptkb:RT-PCR next-generation sequencing
gptkbp:hasIncidenceInThyroidCancer	1-2%
gptkbp:hasMolecularAlteration	gptkb:RET_gene_fusion
gptkbp:hasTargetedTherapy	gptkb:pralsetinib gptkb:selpercatinib
gptkbp:prevalence	rare
gptkbp:prognosis	variable
gptkbp:subspecies	gptkb:papillary_thyroid_carcinoma gptkb:anaplastic_thyroid_carcinoma gptkb:poorly_differentiated_thyroid_carcinoma
gptkbp:bfsParent	gptkb:pralsetinib gptkb:selpercatinib gptkb:Selpercatinib
gptkbp:bfsLayer	7
https://www.w3.org/2000/01/rdf-schema#label	RET fusion-positive thyroid cancer